[Solved]: Cagrilintide was recently evaluated with…

Cagrilintide was recently evaluated with semaglutide in 2 phase 3 trials (non-T2DM and T2DM populations, respectively). Which of the following is the most accurate statement regarding gastrointestinal tolerability of this agent in the studies? A. Participants in the T2DM cohort were given prophylactic antinausea medications, which led to less nausea/vomiting. B. Participants in the non-T2DM cohort had significantly more gastroparesis than the T2DM cohort, leading to more nausea and vomiting. C. The combination of the drugs was titrated starting at the lowest doses, leading to primarily mild-to-moderate gastrointestinal adverse effects. D. Semaglutide doses were capped at 1 mg weekly in the T2DM study, leading to less overall hypoglycemia.